arrow
F

Francesco Onida

university of milan
H指数:51
被引数:8,941

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Durable response to lenalidomide rechallenge after azacitidine failure in myelodysplastic neoplasm with del(5q)

病例报告:del(5q)骨髓增生异常肿瘤在阿扎胞苷失败后对来那度胺再挑战获得持久应答

2026-11-140
OA
Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1—viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT

造血干细胞移植和CAR T细胞治疗后中枢神经系统感染并发症的综合征导向性研究,第一部分——病毒性脑炎、脑膜炎和脊髓炎:来自EBMT实践协调与指南委员会的建议

2026-11-050
OA
Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations for systemic treatments and allogeneic hematopoietic cell transplantation from the European Hematology Association, the EORTC Cutaneous Lymphoma Tumours Group, the International Society for Cutaneous Lymphoma, and the Lymphoma Working Party of the EBMT

欧洲血液学协会、欧洲组织肿瘤研究治疗协作组皮肤淋巴瘤肿瘤组、国际皮肤淋巴瘤学会和EBMT淋巴瘤工作组关于高级别真菌病样肉芽肿和Sézary综合征的管理:系统性治疗和异基因造血细胞移植的国际建议

2026-11-050
OAAI
Donor lymphocyte infusions as pre-emptive and therapeutic strategy for post-transplant acute lymphoblastic leukemia relapse: A retrospective single-center analysis on 16 consecutive patients

供者淋巴细胞输注作为移植后急性淋巴细胞白血病复发的预防性和治疗性策略:一项对16例连续患者的回顾性单中心分析

2026-11-040
OAAI
The role of palliative and supportive care in haematopoietic cell transplantation and cellular therapy. Recommendations from the EBMT practice harmonisation and guidelines committee

姑息治疗和支持性护理在造血细胞移植和细胞治疗中的作用。EBMT实践协调与指南委员会的建议

2026-10-260
OAAI
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party

异基因造血细胞移植治疗年轻成人骨髓增生异常综合征:代表EBMT慢性恶性疾病工作组进行的回顾性研究

2026-09-300
OA
Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study

持续缓解(ORR4)作为莫加木单抗治疗蕈样真菌病和塞扎里综合征期间的治疗性预后标志物:FIL-MOGA研究

2026-09-210
OAAI
Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone—a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT

异基因造血细胞移植治疗伴有阵发性睡眠性血红蛋白尿克隆异常的骨髓增生异常综合征——欧洲血液和骨髓移植学会慢性恶性病和重症再生障碍性贫血工作组代为研究

2026-08-130
PRE
Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT)

自体造血干细胞移植治疗自身免疫性疾病的晚期并发症:欧洲血液与骨髓移植学会(EBMT)自身免疫性疾病工作组(ADWP)、移植并发症工作组(TCWP)和儿科疾病工作组(PDWP)的回顾性调查

2026-07-270
PRE
Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee

输血依赖型地中海贫血造血细胞移植的预处理方案:EBMT实践协调与指南委员会的建议

2026-07-220
PRE
Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT

近年来骨髓增生异常综合征患者移植趋势:EBMT慢性恶性疾病工作组登记研究

2026-05-280
OAAI
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging

异基因造血细胞移植后的中枢神经系统并发症:EBMT实践协调和指南委员会关于流行病学、结局和神经影像学的最佳实践建议

2026-05-130
PRE
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee

症状指导方法在异基因造血细胞移植受者中枢神经系统并发症中的应用:EBMT实践协调和指南委员会的最佳实践建议

2026-05-070
PRE
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee

定义异基因造血细胞移植后骨髓增生异常/骨髓增生性肿瘤的缓解和复发,并优化移植结果:EBMT实践协调与指南委员会的建议

2026-04-010
PRE
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

严格的细胞减灭术能否改善进展性慢性髓单核细胞白血病的生存率?

Leukemia
IF13.4
2026-03-090
OAAI
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT

真实世界中Letermovir在成人CMV血清阳性异基因造血细胞移植受者中的使用模式与结局:EBMT传染病工作组开展的一项国际回顾性研究

2026-03-020
PRE
Syndrome-oriented CNS infectious complications after haematopoietic stem-cell transplantation and CAR T-cell therapy, part 2—focal brain infections and meningitis of bacterial, fungal, and parasitic origin: recommendations from the EBMT Practice and Harmonization Committee

造血干细胞移植和CAR T细胞治疗后以综合征为导向的中枢神经系统感染并发症,第2部分——细菌性、真菌性和寄生虫性局灶性脑感染和脑膜炎:EBMT实践与协调委员会的建议

2026-01-010
OA